Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma

Detalhes bibliográficos
Autor(a) principal: Moron, Roberson A.
Data de Publicação: 2018
Outros Autores: Jacob, Carlos Eduardo, Bresciani, Claudio José Caldas, Simões, Kleber, Alves, Venâncio Avancini Ferreira, Irya, Kyoshi, Gama-Rodrigues, Joaquim, Cecconello, Ivan, Longatto, Adhemar, Zilberstein, Bruno
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/58202
Resumo: The aim of the present study was to determine the clinical significance of p53 and p21ras p21wafl, p27kip1 and p16ink4a expression in cases of early gastric cancer. A total of 81 patients who had undergone gastrectomy with D2 lymphadenectomy between 1971 and 2004 were retrospectively investigated. The immunohistochemical expression of p21ras, p53, p21waf1/cip1, p27kip1 and p16ink4a in the tissues was evaluated. In normal, metaplastic and tumoral mucosa, p53 was positive in 53, 87.3, and 87.1% of the cases, respectively. In the same tissues, p21ras was positivE in 85.3, 86 and 96.8%, respectively. Positivity FOR p16ink4a was DETECTED IN 46.3, 91.1 and 86% OF THE CASES, respectively, WHEREAS p27kip1 WAS positiVE IN 60, 94.7 and 95.3%, and p21wafl/cip1 WAS positivE IN 32.4, 72.7 and 71.4% OF THE CASES, respectively. All THE tumors WERE positive for p53. Tumors with lymph node invasion presented WITH OVERexpression (+4) of p53 in 47% of the cases VS. 17% OF patients who DID not HAVE lymph node involvement. THEREFORE, higher expression of p53, p21ras and p21wafl/cip1 IN the tumor exhibited a statistically significant association with lymph node involvement.
id RCAP_c1a65b9b9582bc3e3a2682c6ee8b5e61
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/58202
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinomagastric cancerp21(ras)p53p21(waf1/cip1)p27(kip1)p16(ink4a)Ciências Médicas::Medicina BásicaScience & TechnologyThe aim of the present study was to determine the clinical significance of p53 and p21ras p21wafl, p27kip1 and p16ink4a expression in cases of early gastric cancer. A total of 81 patients who had undergone gastrectomy with D2 lymphadenectomy between 1971 and 2004 were retrospectively investigated. The immunohistochemical expression of p21ras, p53, p21waf1/cip1, p27kip1 and p16ink4a in the tissues was evaluated. In normal, metaplastic and tumoral mucosa, p53 was positive in 53, 87.3, and 87.1% of the cases, respectively. In the same tissues, p21ras was positivE in 85.3, 86 and 96.8%, respectively. Positivity FOR p16ink4a was DETECTED IN 46.3, 91.1 and 86% OF THE CASES, respectively, WHEREAS p27kip1 WAS positiVE IN 60, 94.7 and 95.3%, and p21wafl/cip1 WAS positivE IN 32.4, 72.7 and 71.4% OF THE CASES, respectively. All THE tumors WERE positive for p53. Tumors with lymph node invasion presented WITH OVERexpression (+4) of p53 in 47% of the cases VS. 17% OF patients who DID not HAVE lymph node involvement. THEREFORE, higher expression of p53, p21ras and p21wafl/cip1 IN the tumor exhibited a statistically significant association with lymph node involvement.info:eu-repo/semantics/publishedVersionSpandidos PublicationsUniversidade do MinhoMoron, Roberson A.Jacob, Carlos EduardoBresciani, Claudio José CaldasSimões, KleberAlves, Venâncio Avancini FerreiraIrya, KyoshiGama-Rodrigues, JoaquimCecconello, IvanLongatto, AdhemarZilberstein, Bruno2018-032018-03-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/58202engMoron, R. A., Jacob, C. E., Bresciani, C. J. C., Simões, K., Alves, V. A. F., Irya, K., ... & Zilberstein, B. (2018). Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma. Molecular and Clinical Oncology, 8(3), 477-482.2049-94502049-946910.3892/mco.2017.1545https://www.spandidos-publications.com/mco/8/3/477info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:53:05Zoai:repositorium.sdum.uminho.pt:1822/58202Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:52:22.629571Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
title Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
spellingShingle Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
Moron, Roberson A.
gastric cancer
p21(ras)
p53
p21(waf1/cip1)
p27(kip1)
p16(ink4a)
Ciências Médicas::Medicina Básica
Science & Technology
title_short Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
title_full Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
title_fullStr Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
title_full_unstemmed Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
title_sort Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma
author Moron, Roberson A.
author_facet Moron, Roberson A.
Jacob, Carlos Eduardo
Bresciani, Claudio José Caldas
Simões, Kleber
Alves, Venâncio Avancini Ferreira
Irya, Kyoshi
Gama-Rodrigues, Joaquim
Cecconello, Ivan
Longatto, Adhemar
Zilberstein, Bruno
author_role author
author2 Jacob, Carlos Eduardo
Bresciani, Claudio José Caldas
Simões, Kleber
Alves, Venâncio Avancini Ferreira
Irya, Kyoshi
Gama-Rodrigues, Joaquim
Cecconello, Ivan
Longatto, Adhemar
Zilberstein, Bruno
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Moron, Roberson A.
Jacob, Carlos Eduardo
Bresciani, Claudio José Caldas
Simões, Kleber
Alves, Venâncio Avancini Ferreira
Irya, Kyoshi
Gama-Rodrigues, Joaquim
Cecconello, Ivan
Longatto, Adhemar
Zilberstein, Bruno
dc.subject.por.fl_str_mv gastric cancer
p21(ras)
p53
p21(waf1/cip1)
p27(kip1)
p16(ink4a)
Ciências Médicas::Medicina Básica
Science & Technology
topic gastric cancer
p21(ras)
p53
p21(waf1/cip1)
p27(kip1)
p16(ink4a)
Ciências Médicas::Medicina Básica
Science & Technology
description The aim of the present study was to determine the clinical significance of p53 and p21ras p21wafl, p27kip1 and p16ink4a expression in cases of early gastric cancer. A total of 81 patients who had undergone gastrectomy with D2 lymphadenectomy between 1971 and 2004 were retrospectively investigated. The immunohistochemical expression of p21ras, p53, p21waf1/cip1, p27kip1 and p16ink4a in the tissues was evaluated. In normal, metaplastic and tumoral mucosa, p53 was positive in 53, 87.3, and 87.1% of the cases, respectively. In the same tissues, p21ras was positivE in 85.3, 86 and 96.8%, respectively. Positivity FOR p16ink4a was DETECTED IN 46.3, 91.1 and 86% OF THE CASES, respectively, WHEREAS p27kip1 WAS positiVE IN 60, 94.7 and 95.3%, and p21wafl/cip1 WAS positivE IN 32.4, 72.7 and 71.4% OF THE CASES, respectively. All THE tumors WERE positive for p53. Tumors with lymph node invasion presented WITH OVERexpression (+4) of p53 in 47% of the cases VS. 17% OF patients who DID not HAVE lymph node involvement. THEREFORE, higher expression of p53, p21ras and p21wafl/cip1 IN the tumor exhibited a statistically significant association with lymph node involvement.
publishDate 2018
dc.date.none.fl_str_mv 2018-03
2018-03-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/58202
url http://hdl.handle.net/1822/58202
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Moron, R. A., Jacob, C. E., Bresciani, C. J. C., Simões, K., Alves, V. A. F., Irya, K., ... & Zilberstein, B. (2018). Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma. Molecular and Clinical Oncology, 8(3), 477-482.
2049-9450
2049-9469
10.3892/mco.2017.1545
https://www.spandidos-publications.com/mco/8/3/477
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Spandidos Publications
publisher.none.fl_str_mv Spandidos Publications
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133115598241792